BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 9918565)

  • 1. CYP2D6 Metabolism in Frail Elderly Compared to Non-Frail Elderly: A Pilot Feasibility Study.
    Opdam FL; Modak AS; Mooijaart SP; Louwerens M; de Waal MW; Gelderblom H; Guchelaar HJ
    Drugs Aging; 2015 Dec; 32(12):1019-27. PubMed ID: 26597400
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Majhi PK; Sayyad S; Gaur M; Kedar G; Rathod S; Sahu R; Pradhan PK; Tripathy S; Ghosh G; Subudhi BB
    ACS Omega; 2024 Jun; 9(22):23634-23648. PubMed ID: 38854540
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-Drug-Gene Interactions in Cardiovascular Medicine.
    Asiimwe IG; Pirmohamed M
    Pharmgenomics Pers Med; 2022; 15():879-911. PubMed ID: 36353710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort.
    Dodgen TM; Labuschagne CJ; van Schalkwyk A; Steffens FE; Gaedigk A; Cromarty AD; Alessandrini M; Pepper MS
    Pharmacogenomics J; 2016 Nov; 16(6):566-572. PubMed ID: 26503815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic surgery: a narrative review of pharmacotherapy in pain management.
    Sjövall S; Kokki M; Kokki H
    Drugs; 2015 Nov; 75(16):1867-89. PubMed ID: 26493289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.
    Schoedel KA; Pope LE; Sellers EM
    Clin Drug Investig; 2012 Mar; 32(3):157-69. PubMed ID: 22283559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolealkylamines: biotransformations and potential drug-drug interactions.
    Yu AM
    AAPS J; 2008 Jun; 10(2):242-53. PubMed ID: 18454322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically based modelling of inhibition of metabolism and assessment of the relative potency of drug and metabolite: dextromethorphan vs. dextrorphan using quinidine inhibition.
    Moghadamnia AA; Rostami-Hodjegan A; Abdul-Manap R; Wright CE; Morice AH; Tucker GT
    Br J Clin Pharmacol; 2003 Jul; 56(1):57-67. PubMed ID: 12848776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance.
    Brazell C; Freeman A; Mosteller M
    Br J Clin Pharmacol; 2002 Mar; 53(3):224-31. PubMed ID: 11874384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use.
    Taylor CP; Traynelis SF; Siffert J; Pope LE; Matsumoto RR
    Pharmacol Ther; 2016 Aug; 164():170-82. PubMed ID: 27139517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AVP-923, a combination of dextromethorphan hydrobromide and quinidine sulfate for the treatment of pseudobulbar affect and neuropathic pain.
    Olney N; Rosen H
    IDrugs; 2010 Apr; 13(4):254-65. PubMed ID: 20373255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphan.
    Desmeules JA; Oestreicher MK; Piguet V; Allaz AF; Dayer P
    J Pharmacol Exp Ther; 1999 Feb; 288(2):607-12. PubMed ID: 9918565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice.
    Jurica J; Bartecek R; Zourkova A; Pindurova E; Sulcova A; Kasparek T; Zendulka O
    J Clin Pharm Ther; 2012 Aug; 37(4):486-90. PubMed ID: 22548589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.
    Capon DA; Bochner F; Kerry N; Mikus G; Danz C; Somogyi AA
    Clin Pharmacol Ther; 1996 Sep; 60(3):295-307. PubMed ID: 8841152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain.
    Ehret GB; Daali Y; Chabert J; Rebsamen M; Wolff A; Forster A; Moursli F; Fritschy D; Rossier MF; Piguet V; Dayer P; Gex-Fabry M; Desmeules JA
    Pain Physician; 2013 Jan; 16(1):45-56. PubMed ID: 23340533
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.